Explore publications from the ADORE Study Design, including the trial design and results of an international Phase 3, randomised, placebo-controlled study of daily oral edaravone (FNP122) in people living with ALS.
Clinical Trials & Publications
ADORE Study Results
Related ALS content
-
Medical Education
Explore educational resources designed to support healthcare professionals with up-to-date knowledge on ALS diagnosis, management and care.
-
Patient-focused initiatives
Discover patient-focused initiatives that raise awareness of ALS and support communication with patients and caregivers through practical resources.
STAY UPDATE
Receive curated updates on clinical research, medical education, key publications and Ferrer initiatives in rare neurological diseases. You can unsubscribe at any time.
